CannAmerica Brands Corp.

OTC: CNNXF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Vancouver, BCReports USD

#965 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 31

v0.1 · 5/100 weight · pillars only

↑ workforce scale, Piotroski F · ↓ market scale, return on assets

Methodology →

Revenue TTM

$408.4k

Rev growth YoY (TTM)

+33.6%

Net income (FY)

-$2.7M

Employees

Market cap

$704

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$292.3k386.5k CAD2020

Net income-$2.7M-3.6M CAD2020

Operating income-$744.8k-984.8k CAD2020

Total assets$242.9k305.4k CAD2020

Liabilities$4.0M5.1M CAD2020

Equity-$3.8M-4.8M CAD2020

Revenue trend

FY2018 – FY2020 · USD

$558.5k

FY18

$483.1k

FY19

$292.3k

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

CannAmerica Brands Corp. booked $292.3k in FY2020 revenue, contracting 39% year over year — slower than 79% of Healthcare companies we track, at a -918.8% net margin.

Peers · Healthcare

Ontrak, Inc.——Adhera Therapeutics Inc——Stem Holdings, Inc.——Brain Scientific Inc.——

Key facts

CEOChristophe Cerisey

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersVancouver, BC

ExchangeOTC: CNNXF

Employees65

IPO date2018-12-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.